0,826  0,004  Antipsoriatic
0,814  0,014  Antiinflammatory
0,763  0,005  CYP2C19 substrate
0,760  0,009  CYP2C9 substrate
0,767  0,021  Apoptosis agonist
0,687  0,003  Antiacne
0,672  0,004  Liver fibrosis treatment
0,663  0,012  Prostate cancer treatment
0,665  0,017  TNF expression inhibitor
0,645  0,020  Teratogen
0,645  0,028  Antineoplastic (breast cancer)
0,620  0,027  CYP3A4 substrate
0,608  0,022  Embryotoxic
0,599  0,013  Immunosuppressant
0,590  0,005  Macular degeneration treatment
0,610  0,030  Transcription factor NF kappa B inhibitor
0,572  0,013  AR expression inhibitor
0,547  0,001  Retinoic acid receptor agonist
0,550  0,005  Antiulcerative
0,551  0,018  CYP1A2 substrate
0,545  0,013  Antineoplastic (glioma)
0,544  0,016  Hepatic disorders treatment
0,539  0,013  Antiprotozoal (Leishmania)
0,532  0,010  Antineoplastic (glioblastoma multiforme)
0,519  0,008  Antineoplastic (renal cancer)
0,530  0,020  Antineoplastic (melanoma)
0,529  0,025  Antipruritic, allergic
0,511  0,018  Cardiovascular analeptic
0,506  0,015  Nitric oxide antagonist
0,491  0,004  Neurotrophic factor
0,510  0,026  Antineoplastic (ovarian cancer)
0,485  0,003  Alcohol dehydrogenase substrate
0,510  0,038  Antileukemic
0,499  0,028  5 Hydroxytryptamine release stimulant
0,486  0,016  Antipyretic
0,485  0,022  Antioxidant
0,478  0,026  Spasmolytic
0,480  0,031  Bone diseases treatment
0,504  0,054  Antiarthritic
0,500  0,060  Caspase 9 stimulant
0,460  0,026  Carcinogenic
0,443  0,016  Vascular (periferal) disease treatment
0,465  0,046  Antiprotozoal
0,425  0,018  Eye irritation, high
0,447  0,041  Vasodilator, peripheral
0,424  0,021  Antidiabetic symptomatic
0,402  0,006  Diabetic nephropathy treatment
0,426  0,032  Antineoplastic (cervical cancer)
0,426  0,033  Radioprotector
0,404  0,012  Skin whitener
0,416  0,024  Tumour necrosis factor alpha release inhibitor
0,420  0,029  NOS2 expression inhibitor
0,402  0,016  Skin irritative effect
0,388  0,013  UGT2B7 substrate
0,394  0,021  UDP-glucuronosyltransferase substrate
0,388  0,022  FMO3 substrate
0,385  0,021  Antineoplastic (lymphocytic leukemia)
0,395  0,035  Chemoprotective
0,420  0,061  GST A substrate
0,360  0,003  Transcription factor AP-1 inhibitor
0,361  0,007  Phospholipase A2 inhibitor
0,351  0,009  CYP2B6 inhibitor
0,402  0,061  CYP2C19 inhibitor
0,373  0,034  Proliferative diseases treatment
0,373  0,037  Sensitization
0,347  0,013  Lipid peroxidase inhibitor
0,334  0,004  CDC25B inhibitor
0,378  0,052  FMO1 substrate
0,400  0,074  15-Lipoxygenase inhibitor
0,344  0,021  Platelet adhesion inhibitor
0,351  0,039  Free radical scavenger
0,334  0,025  UGT1A1 substrate
0,341  0,036  Chemopreventive
0,339  0,038  Mutagenic
0,337  0,037  Flavin-containing monooxygenase substrate
0,354  0,056  CYP2D6 substrate
0,298  0,005  ABCA1 expression enhancer
0,379  0,092  5 Hydroxytryptamine release inhibitor
0,288  0,002  Retinoic acid beta receptor agonist
0,289  0,005  TRPA1 agonist
0,339  0,054  Lipoxygenase inhibitor
0,312  0,032  Wound healing agent
0,333  0,058  Antineoplastic (brain cancer)
0,306  0,034  Abortion inducer
0,348  0,079  Stroke treatment
0,270  0,005  Keratolytic
0,345  0,081  Antineoplastic (lung cancer)
0,271  0,016  Succinate dehydrogenase inhibitor
0,376  0,123  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,260  0,007  Porphobilinogen synthase inhibitor
0,322  0,071  Calcium channel activator
0,253  0,006  Aldehyde dehydrogenase substrate
0,310  0,066  Cardioprotectant
0,260  0,018  Glutathione S-transferase substrate
0,281  0,041  Antineoplastic enhancer
0,301  0,061  UGT2B4 substrate
0,243  0,005  Antiemphysemic
0,240  0,004  Ornithine decarboxylase inhibitor
0,329  0,095  CYP2C9 inhibitor
0,260  0,033  Neurotrophic factor enhancer
0,296  0,070  Lipoprotein disorders treatment
0,228  0,005  Adenylate cyclase stimulant
0,229  0,006  Actinic keratosis treatment
0,241  0,019  Aldehyde dehydrogenase inhibitor
0,250  0,029  Hair growth stimulant
0,226  0,010  Growth stimulant
0,241  0,025  Age-related macular degeneration treatment
0,258  0,046  Sedative
0,253  0,042  Hepatoprotectant
0,269  0,059  Gastrin inhibitor
0,242  0,034  Antiviral (Herpes)
0,250  0,043  Non-steroidal antiinflammatory agent
0,256  0,050  Septic shock treatment
0,239  0,039  Antipruritic, non-allergic
0,238  0,041  Antimutagenic
0,231  0,037  Acaricide
0,206  0,020  Farnesoid X receptor antagonist
0,213  0,028  UGT2B10 substrate
0,217  0,037  Prostate disorders treatment
0,263  0,083  Antiosteoporotic
0,182  0,003  Retinoic acid alpha receptor agonist
0,182  0,008  Vanilloid agonist
0,251  0,078  Antihypercholesterolemic
0,222  0,049  UGT1A4 substrate
0,203  0,030  Arachidonic acid antagonist
0,215  0,043  UGT1A3 substrate
0,234  0,063  Antiparkinsonian, rigidity relieving
0,236  0,066  Cytotoxic
0,276  0,105  ICAM1 expression inhibitor
0,206  0,039  Melanin inhibitor
0,263  0,096  Antineoplastic (colorectal cancer)
0,221  0,057  Pneumotoxic
0,165  0,002  Retinoic acid receptor antagonist
0,225  0,062  Anesthetic general
0,299  0,136  Antibacterial
0,187  0,025  Ferrochelatase inhibitor
0,164  0,003  Retinoid X beta receptor agonist
0,289  0,130  Atherosclerosis treatment
0,161  0,002  Retinoic acid gamma receptor agonist
0,251  0,093  Antineoplastic (pancreatic cancer)
0,192  0,034  SULT1A3 substrate
0,252  0,095  Immunostimulant
0,166  0,011  Anabolic
0,195  0,042  Interferon gamma antagonist
0,204  0,051  LDLR expression enhancer
0,242  0,091  Amyotrophic lateral sclerosis treatment
0,244  0,097  Antineoplastic (colon cancer)
0,252  0,108  CTGF expression inhibitor
0,238  0,094  5 Hydroxytryptamine uptake stimulant
0,231  0,089  Tyrosine 3 hydroxylase inhibitor
0,167  0,025  Vanilloid 1 agonist
0,191  0,050  Toxic, respiratory center
0,268  0,127  Ulceration
0,238  0,098  CYP1A2 inhibitor
0,140  0,003  Retinoid X gamma receptor agonist
0,232  0,095  UGT1A9 substrate
0,244  0,108  NOS3 expression inhibitor
0,262  0,128  Antiprotozoal (Plasmodium)
0,254  0,123  Apoptosis antagonist
0,147  0,017  Inducible nitric-oxide synthase inhibitor
0,146  0,019  GST T1-1 substrate
0,167  0,044  Cocaine dependence treatment
0,185  0,065  Growth hormone agonist
0,237  0,118  GST M1-1 substrate
0,160  0,042  Retinoprotector
0,283  0,165  Transcription factor inhibitor
0,134  0,020  Transcription factor NF kappa B stimulant
0,116  0,004  Retinoid X alpha receptor agonist
0,202  0,092  Hypolipemic
0,137  0,031  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,131  0,025  UGT2B11 substrate
0,151  0,046  Cathepsin H inhibitor
0,213  0,109  Antiprotozoal (Trypanosoma)
0,132  0,031  Nitric-oxide synthase inhibitor
0,132  0,033  DOPA decarboxylase inhibitor
0,126  0,027  Thioredoxin inhibitor
0,236  0,138  Antithrombotic
0,100  0,002  Retinoic acid receptor gamma antagonist
0,190  0,094  Antiparasitic
0,099  0,005  Retinoid X receptor agonist
0,190  0,096  Cardiodepressant
0,136  0,041  Photosensitizer
0,152  0,058  Antifungal enhancer
0,211  0,118  Antituberculosic
0,116  0,023  Bile acid receptor antagonist
0,146  0,053  Ca2+-transporting ATPase inhibitor
0,175  0,084  Antihelmintic
0,164  0,074  Muscular dystrophy treatment
0,197  0,107  Vasodilator
0,089  0,003  Retinoic acid alpha receptor antagonist
0,189  0,104  UGT1A6 substrate
0,088  0,004  Cyclophilin A inhibitor
0,130  0,048  SULT1A1 substrate
0,122  0,042  UDP-glucose 4-epimerase inhibitor
0,149  0,069  Protein kinase stimulant
0,114  0,037  Androgen antagonist
0,113  0,037  Potassium channel activator
0,147  0,072  UGT2B15 substrate
0,237  0,166  GABA C receptor rho-3 antagonist
0,101  0,031  Na+ K+ transporting ATPase inhibitor
0,117  0,049  Antiprotozoal (Toxoplasma)
0,071  0,003  Retinoic acid beta receptor antagonist
0,132  0,065  Antihyperlipoproteinemic
0,160  0,092  Lipocortins synthesis antagonist
0,117  0,051  5-Lipoxygenase inhibitor
0,183  0,118  Cytostatic
0,125  0,061  Cholesterol synthesis inhibitor
0,065  0,005  Retinoid X receptor antagonist
0,062  0,002  Retinoid X gamma receptor antagonist
0,161  0,102  Antirickettsial
0,134  0,077  Antineoplastic (squamous cell carcinoma)
0,076  0,019  Heme oxygenase stimulant
0,070  0,014  5-Alpha-reductase inhibitor
0,123  0,067  Sphingosine 1-phosphate receptor 4 antagonist
0,187  0,132  Superoxide dismutase inhibitor
0,070  0,015  Anesthetic inhalation
0,099  0,045  Glutamate release inhibitor
0,080  0,027  Aromatase inhibitor
0,057  0,004  Retinoid X alpha receptor antagonist
0,116  0,065  Microtubule formation inhibitor
0,111  0,060  Electron transport complex I inhibitor
0,077  0,026  Argininosuccinate synthase inhibitor
0,093  0,044  Acetylcholine nicotinic antagonist
0,089  0,040  T cell inhibitor
0,182  0,134  Antihypotensive
0,052  0,004  Calcium-independent phospholipase A2 inhibitor
0,113  0,066  Monophenol monooxygenase inhibitor
0,122  0,076  Antismoking
0,105  0,060  Adenylate kinase inhibitor
0,063  0,018  Nicotinic receptor alpha3 subunit antagonist
0,137  0,093  UGT2B9 substrate
0,084  0,041  Narcotic antagonist
0,120  0,077  Alpha-N-acetylglucosaminidase inhibitor
0,196  0,153  Antimycobacterial
0,104  0,063  GABA C receptor agonist
0,066  0,026  Postcoital contraceptive
0,055  0,016  Parathyroid hormone antagonist
0,041  0,003  Retinoid X beta receptor antagonist
0,075  0,038  Anticholelithogenic
0,125  0,089  Antianorexic
0,140  0,105  Antiviral (Hepatitis C)
0,183  0,149  DNA synthesis inhibitor
0,151  0,117  Sepsis treatment
0,150  0,117  P-glycoprotein inhibitor
0,233  0,200  Analgesic
0,054  0,022  Adenylate cyclase 1 inhibitor
0,115  0,083  Coagulant
0,101  0,069  UGT2B1 substrate
0,138  0,106  Cystic fibrosis treatment
0,117  0,085  Anesthetic
0,072  0,040  Bcl2 antagonist
0,041  0,010  Adenosine uptake inhibitor
0,048  0,017  Heme oxygenase inhibitor
0,149  0,119  Phobic disorders treatment
0,134  0,105  Muscle relaxant
0,040  0,011  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,075  0,047  Aminopeptidase I inhibitor
0,087  0,059  Tocolytic
0,114  0,087  CNS active muscle relaxant
0,056  0,029  Prolyl endopeptidase inhibitor
0,035  0,008  Nicotinic acid receptor 2 antagonist
0,059  0,033  Pregnane X receptor antagonist
0,076  0,050  Vanilloid 4 agonist
0,034  0,008  CYP24 inhibitor
0,033  0,007  Vanilloid 2 agonist
0,043  0,020  Nicotinic receptor beta4 subunit antagonist
0,063  0,040  Antimycoplasmal
0,030  0,007  Vitamin D receptor antagonist
0,075  0,053  SULT1A2 substrate
0,046  0,023  Alpha 1L adrenoreceptor agonist
0,086  0,065  Antidote, mercury
0,255  0,234  Antineoplastic (solid tumors)
0,041  0,020  Nicotinic acid receptor agonist
0,055  0,035  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,065  0,044  Protease 3C (Human rhinovirus) inhibitor
0,077  0,058  Chymotrypsin inhibitor
0,086  0,066  Triose-phosphate isomerase inhibitor
0,037  0,018  HMG CoA reductase inhibitor
0,068  0,049  SULT2A1 substrate
0,116  0,098  Antiparkinsonian, tremor relieving
0,036  0,017  ATP citrate lysase inhibitor
0,037  0,019  Tubulin agonist
0,056  0,040  Leukotriene C antagonist
0,190  0,174  Cholesterol antagonist
0,070  0,056  Glutamate dehydrogenase inhibitor
0,100  0,087  Proteasome inhibitor
0,044  0,030  Geranyltranstransferase inhibitor
0,130  0,117  CF transmembrane conductance regulator agonist
0,122  0,108  CC chemokine 6 receptor antagonist
0,180  0,167  Antifungal
0,207  0,194  Histamine release inhibitor
0,050  0,038  Aconitate hydratase inhibitor
0,041  0,029  Kainate receptor agonist
0,064  0,053  Hypercalcemia treatment
0,093  0,083  Choleretic
0,046  0,036  Cholesterol esterase inhibitor
0,034  0,024  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,160  0,151  VCAM1 expression inhibitor
0,096  0,087  Anesthetic local
0,046  0,037  Glucose-6-phosphate isomerase inhibitor
0,085  0,077  Antiviral (Rhinovirus)
0,096  0,088  Antihypermotility
0,200  0,192  Ca(v)3.3 blocker
0,105  0,098  Contraceptive female
0,051  0,044  Sphingosine kinase 2 inhibitor
0,148  0,141  Aldehyde oxidase inhibitor
0,055  0,049  Sphingosine kinase inhibitor
0,120  0,115  Sigma receptor agonist
0,037  0,032  Membrane dipeptidase inhibitor
0,019  0,014  Progesterone receptor B antagonist
0,038  0,033  Liver X receptor alpha agonist
0,016  0,012  Vitamin D receptor agonist
0,059  0,055  Neuronal nicotinic receptor antagonist
0,123  0,120  Pregnane X receptor agonist
0,163  0,160  5 Hydroxytryptamine 3E antagonist
0,085  0,082  Lanosterol 14 alpha demethylase inhibitor
0,066  0,064  Glycine receptor agonist
0,087  0,085  Phosphodiesterase 6D inhibitor
0,011  0,010  Calcium-dependent phospholipase A2 inhibitor
0,054  0,052  TRPA1 antagonist
0,129  0,129  Movement disorders treatment
0,045  0,044  HCV NS3/NS4A protease inhibitor

